These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37424475)

  • 1. How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?
    Uher D; Yoon L; Garber CE; Montes J
    J Neuromuscul Dis; 2023; 10(5):897-914. PubMed ID: 37424475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise biology of neuromuscular disorders.
    Ng SY; Manta A; Ljubicic V
    Appl Physiol Nutr Metab; 2018 Nov; 43(11):1194-1206. PubMed ID: 29944848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy.
    Janssen MMHP; Horstik J; Klap P; de Groot IJM
    J Neuroeng Rehabil; 2021 May; 18(1):84. PubMed ID: 34020668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy.
    Vry J; Schubert IJ; Semler O; Haug V; Schönau E; Kirschner J
    Eur J Paediatr Neurol; 2014 Mar; 18(2):140-9. PubMed ID: 24157400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trials.
    Wijekoon N; Gonawala L; Ratnayake P; Sirisena D; Gunasekara H; Dissanayake A; Senanayake S; Keshavaraj A; Hathout Y; Steinbusch HWM; Mohan C; Dalal A; Hoffman E; D de Silva KR
    IBRO Neurosci Rep; 2023 Jun; 14():146-153. PubMed ID: 36819775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study.
    Steffensen BF; Lyager S; Werge B; Rahbek J; Mattsson E
    Dev Med Child Neurol; 2002 Sep; 44(9):623-32. PubMed ID: 12227617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of scoliosis in patients with Duchenne muscular dystrophy and spinal muscular atrophy: A literature review.
    Garg S
    J Pediatr Rehabil Med; 2016; 9(1):23-9. PubMed ID: 26966797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Temporomandibular Range of Motion in People With Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.
    Lloyd Morris EH; Estilow T; Glanzman AM; Cusack SV; Yum SW
    Am J Occup Ther; 2020; 74(2):7402205080p1-7402205080p10. PubMed ID: 32204786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
    Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
    Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy.
    Esposito G; Ruggiero R; Savarese M; Savarese G; Tremolaterra MR; Salvatore F; Carsana A
    Clin Chem Lab Med; 2013 Dec; 51(12):2239-45. PubMed ID: 23729582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative complications of scoliosis surgery in patients with Duchenne muscular dystrophy and spinal muscular atrophy, focussing on wound healing disorders.
    Burow M; Forst R; Forst J; Hofner B; Fujak A
    Int J Neurosci; 2017 Jun; 127(6):479-485. PubMed ID: 27251216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy.
    Iftikhar M; Frey J; Shohan MJ; Malek S; Mousa SA
    Pharmacol Ther; 2021 Apr; 220():107719. PubMed ID: 33130193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective.
    Brown V; Merikle E; Johnston K; Gooch K; Audhya I; Lowes L
    J Patient Rep Outcomes; 2023 Dec; 7(1):129. PubMed ID: 38085412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Disease-modifying Therapies on Respiratory Function in People with Neuromuscular Disorders.
    Xiao L; Amin R
    Sleep Med Clin; 2024 Sep; 19(3):473-483. PubMed ID: 39095144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK is mitochondrial medicine for neuromuscular disorders.
    Mikhail AI; Ng SY; Mattina SR; Ljubicic V
    Trends Mol Med; 2023 Jul; 29(7):512-529. PubMed ID: 37080889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy.
    Abreu NJ; Waldrop MA
    Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.
    Sheikh O; Yokota T
    BioDrugs; 2021 Jul; 35(4):389-399. PubMed ID: 34097287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.